We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

ANDA Filing Not Willful Patent Infringement Per Se, Federal Circuit Rules

Law360 (July 29, 2004, 12:00 AM EDT) -- The mere filing of an Abbreviated New Drug Application (ANDA) cannot constitute an act of willful infringement compensable by attorney’s fees under the Hatch-Waxman Act, the U.S. Court of Appeals for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.